Seeking Alpha

M. E. Garza's  Instablog

M. E. Garza
Send Message
M.E. Garza is one of the founders of the biotech and healthcare sector news portal BioMedReports.com. He believes in getting the news from credible sources on the street and often reaches out to CEOs and newsmakers directly for interviews and discussions about their companies. Since he began... More
My company:
BioMedReports.Com
My blog:
Daily Info Feeds and Updates
View M. E. Garza's Instablogs on:
  • OXGN - Oxigene filed an S-3
    Interesting to see that the company has just filed an S-3 Registration:

    sec.gov/Archives/edgar/data/908259/00009...

    This is a filing with the Securities and Exchange Commission (SEC) that is used by a publically traded company to register securities that will be offered to its employees via benefit or incentive plans.

    Read more: www.investopedia.com/terms/s/sec-form-s-...
    Nov 01 8:59 AM | Link | Comment!
  • Week's Big Healthcare Conferences Provide Important Inside Glimpse for Investors
    It's time to pay close attention as healthcare sector companies are out to educate and try to lure investors at two of the year's key investment conferences. For healthcare/biotech investors there are few stages on which to catch, meet and ask questions of biotech leaders bigger than this week's Rodman & Renshaw 13th Annual Healthcare Conference, Sept 11-13 at the Waldorf-Astoria Hotel and the 2011 Morgan Stanley Global Healthcare Conference at the Grand Hyatt Hotel in New York.

    Paying close attention at what some of these companies have to say at these conferences is not only urgently important, but during volatile times like these, crucial.

    As one of Wall Street's senior quantitative analysts said this week, "It's getting harder and harder to be a stock picker in this market. It seems stock fundamentals are taking a back seat to the latest Fed speech, jobs report, news from Europe or policy proposal, depending on the day. So, maybe we should all become macroeconomists?"  The fact is, a vast majority of stocks move in the same direction as the market the last- with some percentage of those stocks as high as 94-95% in the past week.

    To put this into perspective, Quantitative Analyst Rocky White points out that "during the 1980s, the percentage of stocks moving with the market on a daily basis was typically only in the 40s or 50s, and peaked in the 60s during the 1987 crash. The percentage was consistently in the 50s during the tech boom, and then rose pretty significantly when the tech bubble burst. Since then, this metric has remained at a higher level. During this most recent pullback, the number shot higher, reaching just above 80%. Prior to this, the only previous time the percentage jumped this high was at the peak of the 2008 crash".

    Why even try to find good picks in markets like these, when about 90% of stocks are moving in the same direction?

    It's more important than ever to pay attention to trends and make them your friends. You have to learn to read the technical indicators, find bottoms and buy stocks on some of the pull-backs that we're seeing in the markets.

    Big cap stocks are bearish. Some of those firms, particularly with operations in places like Europe where debt finances are in even bigger trouble than they are here, may have nowhere to go but down. Historically, times like these see some of the best performances from emerging company stocks.

    As we've seen in some of the small-cap healthcare markets this week, there are plenty of undervalued emerging companies whose stocks can climb once analysts flag them and/or insiders start buying at suddenly cheap prices. You want to look for those. You want to minimize risk and start finding companies that may be on the verge of-  or have already started- generating more revenues; are anticipating good news/catalysts and which appear to be growing- particularly during difficult financial times while others are down-sizing, not meeting goals, etc.

    In healthcare, you want to find companies with technologies that not only measure up, but realistically have a chance at capturing a nice percentage of their particular market. In some cases, these companies may have the better mouse trap, but take a hard look at how difficult it might be for the market to actually adopt that new technology?

    Companies who show up at these conferences are there to convince you that they are the horse to bet on. Spend time looking at the presentations, check the facts and your gut before jumping in. Even if you can't make it to the conferences, most of these companies put up materials and videos from their presentations on their home pages. Go out of your way to look for them.

    Schaeffer's Investment Research which actively tracks options activity points out that "there has been a 15% increase in short interest since March, although both short interest and panic levels is still far from the peaks seen during the financial crisis." Cautious crowds are growing, but as White points out, "the technical backdrop is not as supportive to them as it has been in the past."  If you're off the sidelines and still trading biotech and healthcare "be open to buying stocks that you like on pullbacks to support, as 'pops' can be equally as sharp as 'drops' in the current environment."

    We saw some of those principals at work last week after calling bottom on the overly punished shares of Cleveland Biolabs (Nasdaq:CBLI) and featuring first-look reports about Ampio Phamacetuicals (Nasdaq:AMPE). Both of those stocks were big winners for our readers this past week.

    We will certainly continue to pay close attention to SANUWAVE Health, Inc. (OTCBB:SNWV) at the conference. Since finishing and submitting stacks of data from their double-blind Phase III clinical trials of their dermaPACE® device for the treatment of diabetic foot ulcers, Rodman will provide that firm the first opportunity to speak to a large group of investors, brokers and analysts about their pending FDA decision. The firm is still undervalued with plenty of cash in the bank. More importantly, some analysts are starting to notice that may be well positioned for a buy-out given the threat their disruptive medical device poses to industry leaders in the multi-billion dollar wound healing space.

    A list of the presenting companies, complete with some of the other new faces we will be monitoring at this week's Rodman conference appear below:

    22nd Century Group, Inc.
    (OTC BB: XXII)
    xxiicentury.com
    23andMe Inc.
    23andme.com
    Aastrom Biosciences, Inc.
    (NASDAQ: ASTM)
    aastrom.com
    ACADIA Pharmaceuticals Inc.
    (NASDAQ: ACAD)
    acadia-pharm.com
    Acceleron Pharma, Inc.
    acceleronpharma.com
    Access Pharmaceuticals, Inc.
    (OTC BB: ACCP)
    accesspharma.com
    AcelRx Pharmaceuticals, Inc.
    (NASDAQ: ACRX)
    acelrx.com
    Adolor Corporation
    (NASDAQ: ADLR)
    adolor.com
    Advanced Cell Technology, Inc.
    (OTC BB: ACTC)
    advancedcell.com
    Advaxis, Inc.
    (OTC BB: ADXS)
    advaxis.com
    ADVENTRX Pharmaceuticals, Inc.
    (NYSE Amex: ANX)
    adventrx.com
    Aeterna Zentaris, Inc.
    (NASDAQ: AEZS)
    aezsinc.com
    Agenus Inc.
    (NASDAQ: AGEN)
    agenusbio.com
    Akorn, Inc.
    (NASDAQ: AKRX)
    akorn.com
    Albany Molecular Research, Inc.
    (NASDAQ: AMRI)
    amriglobal.com
    Alimera Sciences
    (NASDAQ: ALIM)
    alimerasciences.com
    Allon Therapeutics, Inc.
    (TSX: NPC CN)
    allontherapeutics.com
    Alnylam Pharmaceuticals, Inc.
    (NASDAQ: ALNY)
    alnylam.com
    AmpliPhi BioSciences Corporation
    (OTC US: APHB.PK)
    ampliphibio.com
    Anadys Pharmaceuticals, Inc.
    (NASDAQ: ANDS)
    anadyspharma.com
    Anika Therapeutics, Inc.
    (NASDAQ: ANIK)
    anikatherapeutics.com
    Aoxing Pharmaceutical Company
    (NYSE Amex: AXN)
    aoxingpharma.com
    Aradigm Corporation
    (OTC BB: ARDM)
    aradigm.com
    Ariad Pharmaceuticals, Inc.
    (NASDAQ: ARIA)
    ariad.com
    Arno Therapeutics, Inc.
    (OTC BB: ARNI)
    arnothera.com
    Astex Pharmaceuticals, Inc.
    (NASDAQ: ASTX)
    supergen.com
    Atheronova, Inc.
    (OTC BB: AHRO)
    atheronova.com
    Atossa Genetics, Inc.
    atossagenetics.com/
    AtriCure, Inc.
    (NASDAQ: ATRC)
    atricure.com
    http://www.biotechindustry.at/uploads/AVIRgreenHills_128148_XX.jpg AVIR Green Hills Biotechnology
    greenhillsbiotech.com/
    Bacterin International Holdings, Inc.
    (NYSE Amex: BONE)
    bacterin.com
    Banyan Biomarkers, Inc.
    banyanbio.com
    Bio-Path Holdings, Inc.
    (OTC BB: BPTH)
    biopathholdings.com
    BioCryst Pharmaceuticals, Inc.
    (NASDAQ: BCRX)
    biocryst.com
    BioDelivery Sciences International, Inc.
    (NASDAQ: BDSI)
    bdsi.com
    BIOLASE Technology, Inc.
    (NASDAQ: BLTI)
    biolase.com
    BioLineRx, Ltd.
    (Tel Aviv: BLRX)
    biolinerx.com
    Bionovo, Inc.
    (NASDAQ: BNVI)
    bionovo.com
    BioSante Pharmaceuticals Inc.
    (NASDAQ: BPAX)
    biosantepharma.com
    BioSpecifics Technologies Corp.
    (NASDAQ: BSTC)
    biospecifics.com
    Biostar Pharmaceuticals, Inc.
    (NASDAQ: BSPM)
    biostarpharmaceuticals.com
    http://www.bioportfolio.com/static/images/uploaded/logos/corporate/BioTimeInc.jpeg BioTime, Inc.
    (NYSE Amex: BTX)
    biotimeinc.com/
    Biovista Inc.
    biovista.com
    Bohai Pharmaceuticals Group, Inc.
    (OTC BB: BOPH)
    bohaipharma.com
    Capstone Therapeutics Corp.
    (NASDAQ: CAPS)
    capstonethx.com
    http://www.startupgazette.com/wp-content/uploads/2011/03/CardioFocus.jpg CardioFocus, Inc.
    cardiofocus.com
    Cardium Therapeutics, Inc.
    (NYSE Amex: CXM)
    cardiumthx.com
    CAS Medical Systems, Inc.
    (NASDAQ: CASM)
    casmed.com
    Catasys, Inc.
    (OTC BB: CATS)
    catasyshealth.com
    Cell Therapeutics, Inc.
    (NASDAQ: CTIC)
    celltherapeutics.com
    Celsion Corporation
    (NASDAQ: CLSN)
    celsion.com
    Chelsea Therapeutics International, Ltd.
    (NASDAQ: CHTP)
    chelseatherapeutics.com
    China Biologic Products, Inc.
    (NASDAQ: CBPO)
    chinabiologic.com
    ChromaDex Corporation
    (OTC BB: CDXC)
    chromadex.com
    Cipher Pharmaceuticals Inc.
    (TSX: DND CN)
    cipherpharma.com
    Cleveland Biolabs, Inc.
    (NASDAQ: CBLI)
    cbiolabs.com
    CNS Response, Inc.
    (OTC BB: CNSO)
    cnsresponse.com
    Columbia Laboratories, Inc.
    (NASDAQ: CBRX)
    columbialabs.com
    Compugen, Ltd.
    (NASDAQ: CGEN)
    cgen.com
    CorMedix, Inc.
    (NYSE Amex: CRMD)
    cormedix.com
    Coronado Biosciences
    coronadobiosciences.com
    Cortex Pharmaceuticals, Inc.
    (OTC BB: CORX)
    cortexpharm.com
    CryoPort, Inc.
    (OTC BB: CYRX)
    cryoport.com
    CUREMARK
    curemark.com
    Curis, Inc.
    (NASDAQ: CRIS)
    curis.com
    Cynosure, Inc.
    (NASDAQ: CYNO)
    cynosure.com
    Cytokinetics, Inc.
    (NASDAQ: CYTK)
    cytokinetics.com
    Cytomedix, Inc.
    (OTC BB: CMXI)
    cytomedix.com
    Cytosorbents Corporation
    (OTC BB: CTSO)
    cytosorbents.com
    CytRx Corporation
    (NASDAQ: CYTR)
    cytrx.com
    D. Medical Industries
    (NASDAQ: DMED)
    dmedicalindustries.com
    DARA BioSciences, Inc.
    (NASDAQ: DARA)
    darabiosciences.com
    Dehaier Medical Systems
    (NASDAQ: DHRM)
    dehaier.com.cn
    Dendreon Corporation
    (NASDAQ: DNDN)
    dendreon.com
    Derma Sciences, Inc.
    (NASDAQ: DSCI)
    dermasciences.com
    DiagnoCure, Inc.
    (TSX: CUR CN)
    diagnocurelabs.com
    DURECT Corporation
    (NASDAQ: DRRX)
    durect.com
    DUSA Pharmaceuticals, Inc.
    (NASDAQ: DUSA)
    dusapharma.com
    Dyax Corp.
    (NASDAQ: DYAX)
    dyax.com
    Echo Therapeutics, Inc.
    (NASDAQ: ECTE)
    echotx.com
    EDAP TMS S.A.
    (NASDAQ: EDAP)
    edap-tms.com
    Edge Therapeutics, Inc.
    edgetherapeutics.com
    Enzo Biochem, Inc.
    (NYSE: ENZ)
    enzo.com
    EpiCept Corporation
    (NASDAQ: EPCT)
    epicept.com
    EXACT Sciences Corporation
    (NASDAQ: EXAS)
    exactsciences.com
    Fibrocell Science, Inc.
    (OTC BB: FCSC)
    fibrocellscience.com
    Furiex Pharmaceuticals, Inc.
    (NASDAQ: FURX)
    furiex.com
    Galectin Therapeutics Inc.
    (OTC BB: PRWP)
    galectintherapeutics.com
    Generex Biotechnology Corporation
    (NASDAQ: GNBT)
    generex.com
    Genetic Technologies Ltd.
    (NASDAQ: GENE)
    gtglabs.com
    Genta Incorporated
    (OTC BB: GNTA)
    genta.com
    Geron Corporation
    (NASDAQ: GERN)
    geron.com
    Given Imaging Ltd.
    (NASDAQ: GIVN)
    givenimaging.com
    GnuBIO, Inc.
    gnubio.com
    Golden Meditech Holdings Limited
    (Hong Kong: 801 HK)
    goldenmeditech.com
    Heat Biologics, Inc.
    heatbio.com
    Hemispherx Biopharma, Inc.
    (NYSE Amex: HEB)
    hemispherx.net
    Hi-Tech Pharmacal Co., Inc.
    (NASDAQ: HITK)
    hitechpharm.com
    ICU Medical, Inc.
    (NASDAQ: ICUI)
    icumed.com
    Illumina, Inc.
    (NASDAQ: ILMN)
    illumina.com
    Immune Pharmaceuticals
    immunepharmaceuticals.com/
    ImmunoCellular Therapeutics, Ltd
    (OTC BB: IMUC)
    imuc.com
    Infinity Pharmaceuticals, Inc.
    (NASDAQ: INFI)
    ipi.com
    InfuSystem Holdings, Inc.
    (NYSE Amex: INFU)
    infusystem.com
    Inovio Pharmaceuticals, Inc
    (NYSE Amex: INO)
    inovio.com
    InSite Vision Incorporated
    (OTC BB: INSV)
    insitevision.com
    InspireMD, Inc.
    (OTC BB: NSPR)
    inspire-md.com
    Insulet Corporation
    (NASDAQ: PODD)
    insulet.com
    Intelgenx Technologies, Corp.
    (OTC BB: IGXT)
    intelgenx.com
    Intellicell Biosciences, Inc.
    (OTC US: SVFC.PK)
    intellicellbiosciences.com
    International Stem Cell Corporation
    (OTC BB: ISCO)
    intlstemcell.com
    InVivo Therapeutics Corporation
    invivotherapeutics.com
    Jennerex, Inc.
    jennerex.com
    Keryx Biopharmaceuticals, Inc.
    (NASDAQ: KERX)
    keryx.com
    KineMed, Inc.
    kinemed.com
    Kips Bay Medical, Inc.
    (NASDAQ: KIPS)
    kipsbaymedical.com
    Knome, Inc.
    knome.com
    LifeVantage Corporation
    (OTC BB: LFVN)
    lifevantage.com/investor-profile.aspx
    Lineagen, Inc.
    lineagen.com
    MannKind Corporation
    (NASDAQ: MNKD)
    mannkindcorp.com
    Marina Biotech, Inc.
    (NASDAQ: MRNA)
    marinabio.com
    Mazor Robotics Ltd.
    (Tel Aviv: MZOR)
    mazorrobotics.com
    Medicago Inc.
    (TSX: MDG CN)
    medicago.com
    MediGene AG
    (Frankfurt: MDG GR)
    medigene.com
    MethylGene, Inc.
    (TSX: MYG CN)
    methylgene.com
    Millennium HealthCare, Inc.
    (OTC US: MHCC.PK)
    millenniumhcs.com
    Molmed S.p.A
    (Milan: MLM.MI)
    molmed.com
    Momenta Pharmaceuticals, Inc.
    (NASDAQ: MNTA)
    momentapharma.com
      Montigen Pharmaceuticals
    MRI Interventions, Inc.
    mriinterventions.com
    Myrexis, Inc.
    (NASDAQ: MYRX)
    myrexis.com
    NanoViricides, Inc.
    (OTC BB: NNVC)
    nanoviricides.com
    NeoGenomics, Inc.
    (OTC BB: NGNM)
    neogenomics.org
    Neoprobe Corporation
    (NYSE Amex: NEOP)
    neoprobe.com
    Neostem, Inc.
    (NYSE Amex: NBS)
    neostem.com
    Neovacs
    neovacs.com
    Neuralstem, Inc.
    (NYSE Amex: CUR)
    neuralstem.com
    NeurogesX, Inc.
    (NASDAQ: NGSX)
    neurogesx.com
    http://www.wrhambrecht.com/ind/auctions/trad/nuro/images/nuro_logo_160x19.gif NeuroMetrix, Inc.
    neurometrix.com
    Nile Therapeutics, Inc.
    (NASDAQ: NLTX)
    niletherapeutics.com
    NobleGen Biosciences, Inc.
    noblegenbio.com
    Novadaq Technologies Inc.
    (TSX: NDQ CN)
    novadaq.com
    Novelos Therapeutics, Inc.
    (OTC BB: NVLT)
    novelos.com
    Nuvo Research Inc.
    (TSX: NRI CN)
    nuvoresearch.com
    NxStage Medical, Inc.
    (NASDAQ: NXTM)
    nxstage.com
    Oculus Innovative Sciences, Inc.
    (NASDAQ: OCLS)
    oculusis.com
    Omeros Corporation
    (NASDAQ: OMER)
    omeros.com
    Omthera Pharmaceuticals, Inc.
    omthera.com
    OncoGenex Pharmaceuticals, Inc.
    (NASDAQ: OGXI)
    oncogenex.com
    http://www.thestockprofiler.com/images/oncs_22581.gif OncoSec Medical Inc.
    (OTC BB: ONCS)
    oncosec.com
    Oncothyreon, Inc.
    (NASDAQ: ONTY)
    oncothyreon.com
    Opexa Therapeutics, Inc.
    (NASDAQ: OPXA)
    opexatherapeutics.com
    http://www.oramed.com/tmpl/1/img/logo.gif Oramed Pharmaceuticals Inc.
    (OTC BB: ORMP)
    oramed.com
    Orexo AB
    (OME: ORX SS)
    orexo.com
    OXiGENE, Inc.
    (NASDAQ: OXGN)
    oxigene.com
    http://www.kindredsearch.com/resources/1558/Pacific%20Biosciences2010.gif Pacific Biosciences of California, Inc.
    (NASDAQ: PACB)
    pacificbiosciences.com
    Palatin Technologies, Inc.
    (NYSE Amex: PTN)
    palatin.com
    Pivotal Therapeutics Inc.
    (CNSX: PVO)
    pivotaltherapeutics.us
    Pluristem Therapeutics, Inc.
    (NASDAQ: PSTI)
    pluristem.com
    PolyMedix, Inc.
    (OTC BB: PYMX)
    polymedix.com
    Probiodrug AG
    probiodrug.de
    Provectus Pharmaceuticals, Inc.
    (OTC BB: PVCT)
    pvct.com
    pSivida Corp.
    (NASDAQ: PSDV)
    psivida.com
    Quark Pharmaceuticals, Inc.
    quarkpharma.com
    RegeneRx Biopharmaceuticals, Inc.
    (OTC BB: RGRX)
    regenerx.com
    Regulus Therapeutics Inc.
    regulusrx.com
    Repligen Corporation
    (NASDAQ: RGEN)
    repligen.com
    Repros Therapeutics, Inc.
    (NASDAQ: RPRX)
    reprosrx.com
    Resverlogix Corp.
    (TSX: RVX CN)
    resverlogix.com
    Rexahn Pharmaceuticals, Inc.
    (NYSE Amex: RNN)
    rexahn.com
    Rosetta Genomics, Ltd.
    (NASDAQ: ROSGD)
    rosettagenomics.com
    RXi Pharmaceuticals Corp.
    (NASDAQ: RXII)
    rxipharma.com
    Safeguard Scientifics, Inc.
    (NYSE: SFE)
    safeguard.com
    SANUWAVE Health, Inc.
    (OTC BB: SNWV)
    sanuwave.com
    SciClone Pharmaceuticals, Inc.
    (NASDAQ: SCLN)
    sciclone.com
    Senesco Technologies, Inc.
    (NYSE Amex: SNT)
    senesco.com
    Silence Therapeutics plc
    (LONDON: SLN LN)
    silence-therapeutics.com
    Sinobiopharma, Inc.
    (OTC BB: SNBP)
    sinobp.com
    Sinovac Biotech, Ltd.
    (NASDAQ: SVA)
    sinovac.com
    Soligenix, Inc.
    (OTC BB: SNGX)
    soligenix.com
    Spectral Diagnostics Inc.
    (TSX: SDI CN)
    spectraldx.com
    SpectraScience, Inc.
    (OTC BB: SCIE)
    spectrascience.com
    Spectrum Pharmaceuticals, Inc.
    (NASDAQ: SPPI)
    sppirx.com
    Spherix Incorporated
    (NASDAQ: SPEX)
    spherix.com
    Sunesis Pharmaceuticals, Inc.
    (NASDAQ: SNSS)
    sunesis.com
    Sunwin International Neutraceuticals, Inc.
    (OTC BB: SUWN)
    sunwininternational.com
    SuperNova Diagnostics, Inc.
    supernovadiagnostics.com
    SynCardia Systems, Inc.
    syncardia.com
    Synta Pharmaceuticals Corp.
    (NASDAQ: SNTA)
    syntapharma.com
    TearLab Corporation
    (NASDAQ: TEAR)
    tearlab.com
    Tengion, Inc.
    (NASDAQ: TNGN)
    tengion.com
    The Female Health Company
    (NASDAQ: FHCO)
    femalehealth.com
    ThermoGenesis Corp.
    (NASDAQ: KOOL)
    thermogenesis.com
    Thoratec Corporation
    (NASDAQ: THOR)
    thoratec.com
    Threshold Pharmaceuticals, Inc.
    (NASDAQ: THLD)
    thresholdpharm.com
    Transgenomic, Inc.
    (OTC BB: TBIO)
    transgenomic.com
    Transition Therapeutics, Inc.
    (NASDAQ: TTHI)
    transitiontherapeutics.com
    http://media.globenewswire.com/cache/15120/int/10256.jpg Tranzyme, Inc.
    (NASDAQ: TZYM)
    tranzyme.com
    Trimel Pharmaceuticals Corporation
    (TSX: TRL CN)
    Trinity Biotech plc
    (NASDAQ: TRIB)
    trinitybiotech.com
    Unigene Laboratories, Inc.
    (OTC BB: UGNE)
    unigene.com
    Unilife Corporation
    (NASDAQ: UNIS)
    unilife.com
    http://www.russopartnersllc.com/images/client_logo/Veloxis_logo_RGB_Onscreen.jpg Veloxis Pharmaceuticals A/S
    (OME: VELO SS)
    veloxis.com
    http://1centstock.com/wp-content/uploads/2011/08/Ventrus-Biosciences-VTUS-logo-150x112.png Ventrus Biosciences, Inc
    (NASDAQ: VTUS)
    ventrusbio.com
    Vical Incorporated
    (NASDAQ: VICL)
    vical.com
    Viralytics Limited
    (ASX: VLA AU)
    viralytics.com
    VirtualScopics, Inc.
    (NASDAQ: VSCP)
    virtualscopics.com
    Vizio Medical Devices LLC
    viziomedical.com
    Vringo, Inc.
    (NYSE Amex: VRNG)
    vringo.com
    http://www.inda.org/membership/logos/247171.JPG Winner Medical Group Inc.
    (NASDAQ: WWIN)
    winnermedical.com
    YM BioSciences, Inc.
    (NYSE Amex: YMI)
    ymbiosciences.com
    Zalicus, Inc.
    (NASDAQ: ZLCS)
    combinatorx.com
    Ziopharm Oncology, Inc.
    (NASDAQ: ZIOP)
    ziopharm.com


    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
    Sep 12 2:14 AM | Link | Comment!
  • Email question about RPC
    A question representing many of the ones we've gotten via email today:

    -----Original Message-----
    From: "Greg" <****@*********>
    Sent: Friday, June 3, 2011 12:41pm
    Subject: Rpc

    Are you still upbeat about RPC? nothing seems to be going on for them lately..


    Two days ago, as part of our research for an upcoming report we had a long chat over coffee with one of the major note (debt) holders that RPC was supposedly going to have to file banruptcy because of. The gentleman was very pragmatic in telling us that the investment group he is part of all feels good about several very positive things that are continuing to develop at RPC and that his group is very close to working out a deal with the company which, in his words, "will reflect very favorably for the company and their shareholders." When I asked him to handicap that scenario and when it might happen he said "I'm 95% sure it will happen very shortly. Certainly long before the final meeting with the Amex takes place."

    These people have single-handedly bet millions on RPC, and their technology and are very likely aware of certain developments- i.e partnerships, financial projections, that have not yet been made public so to hear those comments was interesting, but certainly not any different from what we have been hearing from other sources about this "incredibly bleak" situation.

    We also thought one of his comments were interesting given today's tabloid article. He said: "If the SEC or Amex had even the slightest hint that anything was suspicious or iffy about the company they would have shut them down already. This is a major U.S. exchange and we know they put the company through the paces during their hearing. We also know that RPC showed up very well prepared and had some big guns on their side; including that SEC investigator who was able to present some overwhelmingly strong evidence in favor of Radient."

    Developing, but the tabloids have obvisouly made some progress which is impressive given that no one will even speak to them given their reputation. We've now gone from "the India order is completely bogus and the the distributor is made up" to "the Indian distributor has financial difficulties." Nice!

    The company is scheduled to make a presentation at ASCO.

    Tags: RXPC
    Jun 03 1:51 PM | Link | 7 Comments
Full index of posts »
Latest Followers

StockTalks

  • Hearing some interesting developments on the horizon for $NWBO. Did an article on them yesterday. Looks promising. http://bit.ly/NWBOnews
    Jul 12, 2011
  • ($RXPC.PK 3 of 3) If it were bad news, chances are they'd have something by now, since delisting decisions are usually handed down quickly.
    Apr 19, 2011
  • ($RXPC.PK 2 of 3) a listing extension would go until July [when the stock would have to be over $1 to continue being listed on Amex].
    Apr 19, 2011
More »

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.